JDVSX
Price
$16.07
Change
+$0.05 (+0.31%)
Updated
Jan 23 closing price
Net Assets
469.72M
RLBCX
Price
$35.26
Change
+$0.11 (+0.31%)
Updated
Jan 23 closing price
Net Assets
242.81B
Ad is loading...

JDVSX vs RLBCX

Header iconJDVSX vs RLBCX Comparison
Open Charts JDVSX vs RLBCXBanner chart's image
JPMorgan Diversified I
Price$16.07
Change+$0.05 (+0.31%)
VolumeN/A
Net Assets469.72M
American Funds American Balanced R3
Price$35.26
Change+$0.11 (+0.31%)
VolumeN/A
Net Assets242.81B
JDVSX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVSX vs. RLBCX commentary
Jan 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVSX is a Hold and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 243B vs. JDVSX (470M). RLBCX pays higher dividends than JDVSX: RLBCX (1.98) vs JDVSX (1.20). JDVSX was incepted earlier than RLBCX: JDVSX (23 years) vs RLBCX (23 years). RLBCX is a more actively managed with annual turnover of: 171.00 vs. JDVSX (94.00). RLBCX has a lower initial minimum investment than JDVSX: RLBCX (250) vs JDVSX (1000000). RLBCX (12.25) and JDVSX (12.13) have marching annual gain over last year. RLBCX return over 5 years is better than : 30.42 vs. JDVSX (5.40).
JDVSXRLBCXJDVSX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD3.1453.37193%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets470M243B0%
Annual Yield % from dividends1.201.9861%
Returns for 1 year12.1312.2599%
Returns for 3 years6.3715.3641%
Returns for 5 years5.4030.4218%
Returns for 10 years13.0753.8724%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDI4.360.10
+2.35%
indie Semiconductor
SYM33.500.21
+0.63%
Symbotic
FLUT267.891.07
+0.40%
Flutter Entertainment plc
SABS3.67-0.05
-1.34%
SAB Biotherapeutics
MVST1.99-0.09
-4.33%
Microvast Holdings